Yoland Smith Selected Research

Yoland Smith Research Topics

Disease

24	Parkinson Disease (Parkinson's Disease) 12/2019 - 01/2006
13	Parkinsonian Disorders (Parkinsonism) 10/2021 - 06/2007
4	Dyskinesias (Dyskinesia) 11/2019 - 04/2008
3	Dystonia (Limb Dystonia) 01/2018 - 06/2013
3	Nervous System Diseases (Neurological Disorders) 12/2015 - 02/2009
3	Schizophrenia (Dementia Praecox) 01/2013 - 12/2011
2	Inflammation (Inflammations) 10/2020 - 07/2014
2	Huntington Disease (Huntington's Disease) 01/2019 - 01/2015
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 03/2009
2	Cognitive Dysfunction 01/2019 - 01/2012
2	Brain Diseases (Brain Disorder) 12/2016 - 09/2015
2	Dystonic Disorders (Writer's Cramp) 10/2015 - 06/2013
2	Substance-Related Disorders (Drug Abuse) 09/2015 - 02/2007
1	Hydrocephalus (Hydrocephaly) 01/2017
1	Disease Progression 07/2015
1	Alzheimer Disease (Alzheimer's Disease) 02/2015
1	Movement Disorders (Movement Disorder) 01/2014
1	Dystonia musculorum deformans type 1 06/2013
1	Rett Syndrome (Rett's Disorder) 01/2013
1	Mental Disorders (Mental Disorder) 01/2012
1	Catalepsy 11/2011
1	Body Weight (Weight, Body) 07/2011
1	Basal Ganglia Diseases (Basal Ganglia Disease) 01/2011
1	Seizures (Absence Seizure) 05/2007
1	Status Epilepticus (Complex Partial Status Epilepticus) 10/2006
1	Epilepsy (Aura) 10/2006

Drug/Important Bio-Agent (IBA)

15	Dopamine (Intropin)FDA LinkGeneric 01/2018 - 04/2006
11	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 10/2020 - 06/2007
6	Levodopa (L Dopa)FDA LinkGeneric 11/2019 - 04/2008
4	Proteins (Proteins, Gene)FDA Link 01/2017 - 03/2009
3	DysbindinIBA 01/2013 - 12/2011
2	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2018 - 02/2007
2	Cholinergic Agents (Cholinergics)IBA 01/2018 - 09/2015
2	Pharmaceutical PreparationsIBA 12/2016 - 02/2012
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2015 - 02/2015
2	Dopamine Agonists (Dopamine Agonist)IBA 10/2015 - 03/2010
2	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 07/2014 - 02/2012
2	gamma-Aminobutyric Acid (GABA)IBA 08/2012 - 04/2006
2	Therapeutic UsesIBA 02/2012 - 02/2009
1	XENP 1595IBA 10/2020
1	Tumor Necrosis Factor InhibitorsIBA 10/2020
1	GuanineIBA 01/2019
1	polyglutamineIBA 01/2019
1	Adenine FDA LinkGeneric 01/2019
1	Cysteine (L-Cysteine)FDA Link 01/2019
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2018
1	T-Type Calcium Channels (T-Type Calcium Channel)IBA 01/2017
1	sodium-hydrogen exchanger regulatory factorIBA 01/2017
1	metabotropic glutamate receptor 4IBA 12/2016
1	Trihexyphenidyl (Artane)FDA LinkGeneric 10/2015
1	Dopamine AntagonistsIBA 10/2015
1	Cholinergic ReceptorsIBA 09/2015
1	Biomarkers (Surrogate Marker)IBA 07/2015
1	Green Fluorescent ProteinsIBA 07/2014
1	Adenosine A2 Receptor AntagonistsIBA 07/2014
1	Codon (Codons)IBA 06/2013
1	GATIBA 08/2012
1	EnzymesIBA 03/2012
1	PeroxiredoxinsIBA 03/2012
1	AntioxidantsIBA 03/2012
1	Haloperidol (Haldol)FDA LinkGeneric 11/2011
1	Metabotropic Glutamate 5 ReceptorIBA 07/2011
1	PyrrolidinesIBA 07/2011
1	pyridineIBA 07/2011
1	Vesicular Glutamate Transport Protein 1IBA 04/2011
1	Ionotropic Glutamate ReceptorsIBA 01/2011
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 12/2010
1	2- carbomethoxy- 3- (4- chlorophenyl)- 8- (2- fluoroethyl)nortropaneIBA 12/2010
1	LigandsIBA 12/2010
1	metabotropic glutamate receptor type 1IBA 06/2007
1	Amino Acid Transport System X-AG (Glutamate Transporter)IBA 05/2007
1	Anticonvulsants (Antiepileptic Drugs)IBA 05/2007
1	Messenger RNA (mRNA)IBA 05/2007
1	Pilocarpine (Ocusert)FDA LinkGeneric 10/2006

Therapy/Procedure

8	Therapeutics 01/2018 - 09/2007
5	Denervation 10/2021 - 02/2009
2	Deep Brain Stimulation 01/2014 - 11/2013
2	Injections 07/2011 - 12/2010
2	Drug Therapy (Chemotherapy) 01/2011 - 01/2006
1	Ketogenic Diet 05/2007